Clinical Trial Update: Effects of Erythropoietin on Cerebral Vascular Dysfunction and Anemia in Traumatic Brain Injury [Phase 2, Phase 3]

View source ↗

Summary

This update reports results from Phase 2 and Phase 3 trials evaluating erythropoietin for anemia and cerebral vascular dysfunction in traumatic brain injury, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Traumatic Brain Injury

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Claudia Sue Robertson | Conditions: Anemia, Traumatic Brain Injury | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-09-10